Jacobson Pharma Corporation

Jacobson Pharma Corporation EBIT per Share

The EBIT per Share of Jacobson Pharma Corporation (2633.HK) as of Oct 13, 2026 is 0.18 HKD. In the previous year, EBIT per Share was 0.21 HKD — a change of -14.97% (lower).

EBIT per Share

0.18HKD

YoY

-14.97%

Last updated:

EBIT per Share of Jacobson Pharma Corporation is 2026 0.18 HKD. EBIT per Share of Jacobson Pharma Corporation was 2025 0.21 HKD. It decreases by -14.97% lower compared to the previous year.

The Jacobson Pharma Corporation EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2029 (e)
0.26 HKD
Jan 1, 2030 (e)
0.13 HKD
Jan 1, 2031 (e)
0.14 HKD
Jan 1, 2032 (e)
0.16 HKD
Jan 1, 2033 (e)
0.19 HKD
Jan 1, 2034 (e)
0.22 HKD
Jan 1, 2035 (e)
0.23 HKD
Jan 1, 2036 (e)
0.30 HKD
The Jacobson Pharma Corporation EBIT per Share history
YEAREBIT per ShareYoY
est0.30HKD+28.53%
est0.23HKD+7.83%
est0.22HKD+13.31%
est0.19HKD+19.85%
est0.16HKD+11.34%
est0.14HKD+13.45%
est0.13HKD-51.38%
est0.26HKD+11.19%
est0.23HKD+9.30%
est0.21HKD+20.95%
0.18HKD-14.97%
0.21HKD+23.70%
0.17HKD+0.56%
0.17HKD+43.73%
0.12HKD+19.97%
0.10HKD-37.18%
0.15HKD-12.23%
0.18HKD+21.05%
0.15HKD+3.63%
0.14HKD+12.50%
0.12HKD+56.86%
0.08HKD-37.72%
0.13HKD—
Access this data via the Eulerpool API
Get Free API Key

Jacobson Pharma Corporation Stock analysis

What does Jacobson Pharma Corporation do? Jacobson Pharma Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jacobson Pharma Corporation stock

EBIT per Share of Jacobson Pharma Corporation is 0.18 HKD in 2026.

EBIT per Share of Jacobson Pharma Corporation changed from 0.21 HKD to 0.18 HKD, representing a -14.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Jacobson Pharma Corporation since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Jacobson Pharma Corporation

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Jacobson Pharma Corporation